Home

Sandu Pharmaceuticals Ltd EPS

Image

Sandu Pharmaceuticals Ltd

NSE: SANDUPHARMA

EPS

₹ 1.51

Last updated on: Apr 02, 2025

Key Highlights

  • The Earning per Share of Sandu Pharmaceuticals Ltd is ₹ 1.51 as of 02 Apr 25 .
  • The earning per share of Sandu Pharmaceuticals Ltd changed from ₹ 0.11 to ₹ 1.95 over 6 quarters. This represents a CAGR of 579.87% .

Historical Earning per Share of Sandu Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Sandu Pharmaceuticals Ltd

Market Cap

48 Cr

EPS

1.5

P/E Ratio (TTM)

33.1

P/B Ratio (TTM)

1.2

Day’s High

51.39

Day’s Low

48.4

DTE

0.0

ROE

3.6

52 Week High

69.5

52 Week Low

45.15

ROCE

5.3

Market Price of Sandu Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Sandu Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
02 Apr 202550
01 Apr 202550
28 Mar 202548.99
27 Mar 202546.23
26 Mar 202549.19
25 Mar 202550.22
24 Mar 202551.8
21 Mar 202552.69
20 Mar 202551.47
19 Mar 202551.99

BlinkX Score for Sandu Pharmaceuticals Ltd

Asset Value vs Market Value of Sandu Pharmaceuticals Ltd

Market Value

48

Asset Value

Value addition

1.2 X

22

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Sandu Pharmaceuticals Ltd48.3
Sun Pharmaceutical Industries Ltd411306
Divis Laboratories Ltd150343
Cipla Ltd117323
Torrent Pharmaceuticals Ltd108614
Mankind Pharma Ltd99891

Historical Market Cap of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Sandu Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Sandu Pharmaceuticals Ltd News Hub

Sandu Pharmaceuticals AGM scheduled

Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he

Read more

13 Aug 24

Board of Sandu Pharmaceuticals recommends final dividend

Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12

Read more

13 Aug 24

Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Sandu Pharmaceuticals schedules board meeting

Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024

Read more

06 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Sandu Pharmaceuticals Ltd

What is the EPS of Sandu Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Sandu Pharmaceuticals Ltd is 1.51. An EPS is the amount of net income attributed to each share of a common stock.

How is Sandu Pharmaceuticals Ltd EPS calculated?

The EPS of Sandu Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Sandu Pharmaceuticals Ltd report its EPS?

Sandu Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Sandu Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Sandu Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Sandu Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Sandu Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions